International Collaboration in Primary Ciliary Dyskinesia
Pediatric Pulmonology · 2026-11 · 61 (11)
DOI: 10.1002/ppul.71888 ↗At a glance
Übersichtsarbeit in Pediatric Pulmonology, published online on 2026-10-28. Written by Petra Pennekamp and 2 co-authors. Institution: Department of General Pediatrics, University Children's Hospital Muenster, Muenster, Germany. Major MEDLINE topics: International Cooperation, Kartagener Syndrome, Biomedical Research, Ciliary Motility Disorders. 203 references. The full text is freely available (open access, CC BY 4.0). Funded by: Funding to the lab of HO provided by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), The Interdisziplinäres Zentrum für Klinische Forschung Muenster (IZKF), The Federal Ministry of Research, Technology and Space.
Abstract (original language)
Primary Ciliary Dyskinesia (PCD) exemplifies how international collaboration can transform the study of a rare disease. Since the identification of the first PCD‐associated genes in 1999–2002, parallel developments in Europe and North America, driven by patient organizations, academic investigators, and coordinated funding initiatives, have progressively converged into a unified global research infrastructure. Early milestones included the founding of patient advocacy groups, the NIH‐funded Genetic Disorders of Mucociliary Clearance Consortium, and European projects such as EUCILIA and SYSCILIA, which respectively established coordinated clinical research infrastructure and advanced ciliary systems biology. The 2012 EU‐funded BESTCILIA project formalized transatlantic collaboration, establishing the International PCD Registry and iPCD Cohort, generating the first robust diagnostic evidence base, and enabling the first multinational randomized controlled trial in PCD. This infrastructure was subsequently sustained and expanded through the BEAT‐PCD COST Action and its successor ERS Clinical Research Collaboration, the ERN‐LUNG PCD Core Network, and the PCD Clinical Trial Network, alongside parallel North American developments including the PCD Foundation Clinical and Research Centers and PCDF Network for Clinical Trials. Together, these initiatives have harmonized diagnostic pathways, produced joint ERS/ATS diagnostic guidelines, and created durable platforms for multinational trials and registries. Dedicated scientific meetings, culminating in the planned 2026 Global PCD Congress, further embody this convergence. Despite this progress, disparities in global representation and diagnostic access remain, underscoring the need for continued international coordination as the field moves toward precision medicine approaches.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of General Pediatrics, University Children's Hospital Muenster, Muenster, Germany.
- European Reference Network for Rare Respiratory Diseases (ERN-LUNG), Frankfurt am Main, Germany.
- PCD Foundation, Minneapolis, Minnesota, USA.
ORCID profiles: Petra Pennekamp, Michele Manion, Heymut Omran
Funding
- Funding to the lab of HO provided by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
- The Interdisziplinäres Zentrum für Klinische Forschung Muenster (IZKF)
- The Federal Ministry of Research, Technology and Space
Cite
APA
Pennekamp, P., Manion, M., & Omran, H. (2026). International Collaboration in Primary Ciliary Dyskinesia. Pediatric Pulmonology, 61(11). https://doi.org/10.1002/ppul.71888
Vancouver
Pennekamp P, Manion M, Omran H. International Collaboration in Primary Ciliary Dyskinesia. Pediatric Pulmonology. 2026;61(11). doi:10.1002/ppul.71888
BibTeX
@article{Pennekamp2026,
author = {Pennekamp, Petra and Manion, Michele and Omran, Heymut},
title = {International Collaboration in Primary Ciliary Dyskinesia},
journal = {Pediatric Pulmonology},
year = {2026},
volume = {61},
number = {11},
doi = {10.1002/ppul.71888}
}
EUVIMED